These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9112626)

  • 1. Effect of butobendin on dopamine beta-hydroxylase in vitro.
    Grabowska M; Gumińska M
    Pol J Pharmacol; 1996; 48(1):39-45. PubMed ID: 9112626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Craviten, a new antiarrhythmic drug, its 2R, 2'R isomer, quinidine and procaine amide on human platelet aggregation.
    Kedryna T; Gumińska M; Eckstein M
    Pol J Pharmacol Pharm; 1980; 32(6):883-8. PubMed ID: 7243684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Craviten on blood dopamine beta-hydroxylase activity].
    Grabowska M; Gumińska M; Eckstein M
    Folia Med Cracov; 1980; 22(3-4):359-66. PubMed ID: 7286841
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating dopamine-beta-hydroxylase in the rat: importance of altered disposal pathways in experimental diabetes.
    Hurst JH; Nisula BC; Stolk JM
    J Pharmacol Exp Ther; 1982 Jan; 220(1):108-14. PubMed ID: 7031223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental diabetes: alterations in circulating dopamine-beta-hydroxylase and norepinephrine.
    Berkowitz BA; Head R; Joh T; Hempstead J
    J Pharmacol Exp Ther; 1980 Apr; 213(1):18-23. PubMed ID: 6444670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.
    Bonifácio MJ; Sousa F; Neves M; Palma N; Igreja B; Pires NM; Wright LC; Soares-da-Silva P
    Eur J Pharmacol; 2015 Mar; 751():50-8. PubMed ID: 25641750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms and low plasma activity of dopamine-beta-hydroxylase in ADHD children.
    Kopecková M; Paclt I; Goetz P
    Neuro Endocrinol Lett; 2006 Dec; 27(6):748-54. PubMed ID: 17187001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship to survival of catecholamine levels and dopamine-beta-hydroxylase activity in experimental haemorrhagic shock.
    Tárnoky K; Nagy S
    Acta Physiol Hung; 1983; 61(1-2):59-68. PubMed ID: 6637523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic efficiency of Craviten and changes in the activities of serum dopamine beta-hydroxylase and erythrocyte membrane ATPases.
    Gumińska M; Król W; Grabowska M; Grodecki J; Kawecka-Jaszcz K
    Cor Vasa; 1986; 28(5):350-5. PubMed ID: 3024906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of buthobendin on glycolysis in rabbit myocardial slices in vitro.
    Marchut E; Gumińska M; Kedryna T
    Pol J Pharmacol Pharm; 1988; 40(2):167-72. PubMed ID: 3237566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a new antiarrhythmic drug: Craviten (M-71) on the ATP level in heart muscle slices in vitro.
    Gumińska M; Kedryna T; Marchut E; Eckstein M
    Pol J Pharmacol Pharm; 1980; 32(6):877-82. PubMed ID: 7243683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The search for new antiarrhythmics in the group of chirally 1,2-aminoalcohols. I. 3',4',5'-trimethoxybenzoic acid esters of optically active N,N'-dimethyl-N,N'-bis-(1-hydroxybutyl-2) ethylenediamines.
    Eckstein M; Herdegen E
    Pol J Pharmacol Pharm; 1980; 32(6):817-21. PubMed ID: 7243678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary catecholamine excretion and plasma dopamine-beta-hydroxylase activity during mental work performed in some periods of menstrual cycle in women.
    Wasilewska E; Swiecka E; Bargiel Z
    Acta Physiol Pol; 1980; 31(6):647-51. PubMed ID: 7246197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-beta-hydroxylase effectors in neuroblastoma.
    Brewster MA; Berry DH
    Ann Clin Lab Sci; 1979; 9(4):343-6. PubMed ID: 485096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of dopamine in plasma, activity of dopamine beta-hydroxylase in serum and urinary excretion of free catecholamines and vanillylmandelic acid in women chronically exposed to carbon disulphide.
    Stanosz S; Kuligowski D; Pieleszek A; Zuk E; Rzechuła D; Chlubek D
    Int J Occup Med Environ Health; 1994; 7(3):257-61. PubMed ID: 7842240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.
    Kim CH; Zabetian CP; Cubells JF; Cho S; Biaggioni I; Cohen BM; Robertson D; Kim KS
    Am J Med Genet; 2002 Mar; 108(2):140-7. PubMed ID: 11857564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase.
    Palatini P; Dabbeni-Sala F; Finotti P
    Biochem Int; 1984 Dec; 9(6):675-82. PubMed ID: 6525203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic N-hydroxyguanidines as new reduction cosubstrates for dopamine beta-hydroxylase.
    Slama P; Boucher JL; Réglier M
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1081-7. PubMed ID: 15044095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Hydroxyguanidines oxidation by a N3S copper-complex mimicking the reactivity of Dopamine beta-Hydroxylase.
    Slama P; Boucher JL; Réglier M
    J Inorg Biochem; 2009 Mar; 103(3):455-62. PubMed ID: 19178946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.